首页 > 最新文献

Acta Clinica Belgica最新文献

英文 中文
Appropriateness of alert antibiotics measured by repeated prevalence surveys and impact of direct prescriber interaction and feedback. 通过反复流行病学调查和处方者直接互动和反馈的影响来衡量警戒抗生素的适当性。
IF 1.6 4区 医学 Q2 Medicine Pub Date : 2023-02-01 DOI: 10.1080/17843286.2022.2059981
Elise Willems, Hannah Min Jou, Franky Buyle, Veroniek Saegeman, Steven Callens

Objectives: Hospital point prevalence surveys (PPS) are shown to help identifying determinants for inappropriate antimicrobial therapy (AMT) and create feedback opportunities to optimize AMT.

Methods: PPS were performed at the AZNikolaas hospital, on four wards with high consumption rates of three alert antibiotics (AB) to judge their appropriateness. The impact of a multidisciplinary interaction between a medical microbiologist, a clinical pharmacist and the prescriber on inappropriate AMT, hospital costs and intravenous AMT days, was analyzed.

Results: During this survey, 7,39% of hospitalized patients in the selected wards received one or more of three alert antibiotics. Out of 78 prescriptions, 35.90% were judged appropriate, 39.74% inappropriate and 24.36% had insufficient data for judgment. Only the oncology ward was associated with more frequent appropriate use of alert AB. In case of an unknown infection focus or a catheter-related infection, the relative risk of inappropriate use was the highest. Multidisciplinary interaction improved inappropriate AMT in 59% of cases. It resulted in a 2478€ healthcare AMT cost saving and a reduction of 30 intravenous AMT days.

Conclusions: This survey shows high consumption rates and a high rate of inappropriate use of three alert AB in the observed wards. It revealed the lack of a local guideline concerning treatment of neutropenic fever of unknown origin and the need for more diagnostic information in electronical medical records. The survey demonstrated that direct feedback on inappropriate AMT to clinicians can be of added value, cost-saving and reducing length of intravenous AMT days. However, more studies are needed to confirm this.

目的:医院点流行率调查(PPS)被证明有助于确定不适当抗菌药物治疗(AMT)的决定因素,并为优化AMT创造反馈机会。方法:在AZNikolaas医院对3种警戒类抗生素(AB)使用率较高的4个病房进行PPS,判断其适宜性。分析了医学微生物学家、临床药师和开处方者之间的多学科互动对不适当的AMT、医院费用和静脉AMT天数的影响。结果:在本次调查中,有7.39%的住院患者接受了一种或三种警示抗生素。78张处方中,判定适宜的占35.90%,判定不适宜的占39.74%,判定资料不足的占24.36%。只有肿瘤病房更频繁地适当使用警戒AB。在未知感染病灶或导管相关感染的情况下,不适当使用的相对风险最高。在59%的病例中,多学科互动改善了不适当的AMT。它节省了2478欧元的医疗保健AMT费用,并减少了30天的静脉AMT。结论:本调查显示,三警AB在观察病房的使用率和不合理使用率均较高。报告显示,当地缺乏关于治疗来历不明的中性粒细胞减少热的指导方针,需要在电子病历中提供更多的诊断信息。调查表明,直接向临床医生反馈不适当的AMT可以增加价值,节省成本并缩短静脉AMT天数。然而,需要更多的研究来证实这一点。
{"title":"Appropriateness of alert antibiotics measured by repeated prevalence surveys and impact of direct prescriber interaction and feedback.","authors":"Elise Willems,&nbsp;Hannah Min Jou,&nbsp;Franky Buyle,&nbsp;Veroniek Saegeman,&nbsp;Steven Callens","doi":"10.1080/17843286.2022.2059981","DOIUrl":"https://doi.org/10.1080/17843286.2022.2059981","url":null,"abstract":"<p><strong>Objectives: </strong>Hospital point prevalence surveys (PPS) are shown to help identifying determinants for inappropriate antimicrobial therapy (AMT) and create feedback opportunities to optimize AMT.</p><p><strong>Methods: </strong>PPS were performed at the AZNikolaas hospital, on four wards with high consumption rates of three alert antibiotics (AB) to judge their appropriateness. The impact of a multidisciplinary interaction between a medical microbiologist, a clinical pharmacist and the prescriber on inappropriate AMT, hospital costs and intravenous AMT days, was analyzed.</p><p><strong>Results: </strong>During this survey, 7,39% of hospitalized patients in the selected wards received one or more of three alert antibiotics. Out of 78 prescriptions, 35.90% were judged appropriate, 39.74% inappropriate and 24.36% had insufficient data for judgment. Only the oncology ward was associated with more frequent appropriate use of alert AB. In case of an unknown infection focus or a catheter-related infection, the relative risk of inappropriate use was the highest. Multidisciplinary interaction improved inappropriate AMT in 59% of cases. It resulted in a 2478€ healthcare AMT cost saving and a reduction of 30 intravenous AMT days.</p><p><strong>Conclusions: </strong>This survey shows high consumption rates and a high rate of inappropriate use of three alert AB in the observed wards. It revealed the lack of a local guideline concerning treatment of neutropenic fever of unknown origin and the need for more diagnostic information in electronical medical records. The survey demonstrated that direct feedback on inappropriate AMT to clinicians can be of added value, cost-saving and reducing length of intravenous AMT days. However, more studies are needed to confirm this.</p>","PeriodicalId":7086,"journal":{"name":"Acta Clinica Belgica","volume":null,"pages":null},"PeriodicalIF":1.6,"publicationDate":"2023-02-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"9095898","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
The 20-valent pneumococcal conjugate vaccine (PCV20): expected added value. 20价肺炎球菌结合疫苗(PCV20):预期附加价值。
IF 1.6 4区 医学 Q2 Medicine Pub Date : 2023-02-01 DOI: 10.1080/17843286.2022.2039865
Esther Janssens, Johan Flamaing, Corinne Vandermeulen, Willy E Peetermans, Stefanie Desmet, Paul De Munter

Objectives: Currently existing pneumococcal vaccines have contributed to a major reduction in pneumococcal disease. However, there remains an unmet need for vaccine coverage of serotypes not included in PCV13 to further reduce the burden of disease. The objective of this review is to assess the potential impact of implementation of the investigational 20-valent pneumococcal conjugate vaccine (PCV20) in the childhood and adult immunization programme in Belgium and Europe.

Methods: A literature search was conducted to identify publications and surveillance reports concerning the effectiveness and safety of pneumococcal vaccines, epidemiological data on pneumococcal disease or serotype distribution dynamics after introduction of systematic vaccination.

Results: Serotypes included in PCV20 currently account for the majority of pneumococcal disease in Belgium and Europe. In Belgium, PCV20-serotypes accounted for 71.4% of invasive pneumococcal disease (IPD) cases across all age groups in 2019, of which 39.2% were caused by PCV20-non-PCV13-serotypes. In Europe, these seven serotypes accounted for 37,6% of IPD cases in 2018.  PCV20 has proven to be well tolerated in vaccine-naïve adults and elicits a substantial immune response against all serotypes included.

Conclusion: Due to serotype replacement following the introduction of PCV7 and PCV13, a considerable proportion of pneumococcal disease is currently caused by PCV20-serotypes. PCV20 has the potential of preventing more pneumococcal disease in children and the adult population at risk than the existing conjugate vaccines. The available evidence on safety and immunogenicity of PCV20 is promising, but further research is needed to provide data about vaccine effectiveness, immune response duration and replacement phenomenon after introduction of PCV20.

目的:目前现有的肺炎球菌疫苗已大大减少了肺炎球菌疾病。然而,为进一步减轻疾病负担,对PCV13未包括的血清型的疫苗覆盖需求仍未得到满足。本综述的目的是评估在比利时和欧洲实施研究性20价肺炎球菌结合疫苗(PCV20)在儿童和成人免疫规划中的潜在影响。方法:通过文献检索,找出有关肺炎球菌疫苗的有效性和安全性、肺炎球菌疾病的流行病学资料或引入系统疫苗接种后血清型分布动态的出版物和监测报告。结果:PCV20包含的血清型目前占比利时和欧洲肺炎球菌疾病的大多数。在比利时,2019年pcv20血清型占所有年龄组侵袭性肺炎球菌病(IPD)病例的71.4%,其中39.2%是由pcv20 -非pcv13血清型引起的。在欧洲,这7种血清型占2018年IPD病例的37.6%。PCV20已被证明在vaccine-naïve成人中具有良好的耐受性,并引起对包括所有血清型在内的大量免疫应答。结论:由于引入PCV7和PCV13后的血清型替代,目前相当比例的肺炎球菌疾病是由pcv20血清型引起的。与现有的结合疫苗相比,PCV20在高危儿童和成人人群中具有预防更多肺炎球菌疾病的潜力。现有证据表明PCV20的安全性和免疫原性是有希望的,但需要进一步的研究来提供疫苗有效性、免疫反应持续时间和引入PCV20后的替代现象的数据。
{"title":"The 20-valent pneumococcal conjugate vaccine (PCV20): expected added value.","authors":"Esther Janssens,&nbsp;Johan Flamaing,&nbsp;Corinne Vandermeulen,&nbsp;Willy E Peetermans,&nbsp;Stefanie Desmet,&nbsp;Paul De Munter","doi":"10.1080/17843286.2022.2039865","DOIUrl":"https://doi.org/10.1080/17843286.2022.2039865","url":null,"abstract":"<p><strong>Objectives: </strong>Currently existing pneumococcal vaccines have contributed to a major reduction in pneumococcal disease. However, there remains an unmet need for vaccine coverage of serotypes not included in PCV13 to further reduce the burden of disease. The objective of this review is to assess the potential impact of implementation of the investigational 20-valent pneumococcal conjugate vaccine (PCV20) in the childhood and adult immunization programme in Belgium and Europe.</p><p><strong>Methods: </strong>A literature search was conducted to identify publications and surveillance reports concerning the effectiveness and safety of pneumococcal vaccines, epidemiological data on pneumococcal disease or serotype distribution dynamics after introduction of systematic vaccination.</p><p><strong>Results: </strong>Serotypes included in PCV20 currently account for the majority of pneumococcal disease in Belgium and Europe. In Belgium, PCV20-serotypes accounted for 71.4% of invasive pneumococcal disease (IPD) cases across all age groups in 2019, of which 39.2% were caused by PCV20-non-PCV13-serotypes. In Europe, these seven serotypes accounted for 37,6% of IPD cases in 2018.  PCV20 has proven to be well tolerated in vaccine-naïve adults and elicits a substantial immune response against all serotypes included.</p><p><strong>Conclusion: </strong>Due to serotype replacement following the introduction of PCV7 and PCV13, a considerable proportion of pneumococcal disease is currently caused by PCV20-serotypes. PCV20 has the potential of preventing more pneumococcal disease in children and the adult population at risk than the existing conjugate vaccines. The available evidence on safety and immunogenicity of PCV20 is promising, but further research is needed to provide data about vaccine effectiveness, immune response duration and replacement phenomenon after introduction of PCV20.</p>","PeriodicalId":7086,"journal":{"name":"Acta Clinica Belgica","volume":null,"pages":null},"PeriodicalIF":1.6,"publicationDate":"2023-02-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"10585558","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 8
Abstracts presented at the 26th Annual Congress of the Belgian Society of Internal Medicine, 9-10 December 2022, Dolce La Hulpe, La Hulpe, Belgium 2022年12月9日至10日在比利时拉胡尔佩多尔斯举行的比利时内科学会第26届年会上发表的摘要
IF 1.6 4区 医学 Q2 Medicine Pub Date : 2022-12-05 DOI: 10.1080/17843286.2022.2149807
Liselot Vandenbergen, Charline Leclercq, J. D. Greef, J. Yombi, H. Yildiz, Veerle Beckers, Shula Staessens, Sabine Allard, Rik Schots, L. Pothen, Ana Strezova, Javier Diez-Domingo, Kamal Al Shawafi, Juan Carlos Tinoco, Meng Shi, Paola Pirrotta, Angnes Mwakingwe-Omari, Florence Strubbe, Hernan Valdes-Socin, O. Calvete, Javier Benitez, Edouard Louis, P. Petrossians, S. Henrard, Nicola Trotta, Tim Coolen, Delphine Puttaert, J. Goffard, J. Vooren
Background Dry weight is defined as the lowest tolerated post-dialysis weight at which there are minimal signs or symptoms of hypovolemia or hypervolemia. Achieving dry weight is a goal for each dialysis session. That improves blood pressure control and reduces cardiovascular risk in dialysis patients. Haemodialysis patients may experience weight loss likely related to a reduction of dry mass when catabolic reactions and inflammation occur. Our aim was to assess the impact of SARSCov-2 infection on haemodialysis patients and analyse factors associated with dry weight variations observed during the COVID-19 pandemic. Method(s): In this retrospective observational single-centre study, we analysed the clinical characteristics of all patients undergoing haemodialysis at the Pole Hospitalier Jolimont during COVID-19 pandemic from 1 March 2020 to 28 February 2022. We determined dry weight at day 1 after diagnosis of SARSCov-2 infection or at day 1 of a randomly assigned 28-days observation period and at 2, 3 and 4 weeks later. We compared infected and uninfected patients and examined the clinical features associated with SARSCov-2 infection and those associated with changes in dry weight. Result(s): Within the observation period, among the 162 haemodialysis patients, 47 patients were infected with SARSCov-2. Three patients were excluded because they have been infected before the first dialysis session and seventeen others due to missing data. Two patients were infected twice but we considered the second episodes as relevant and had therefore 144 observations. Dry weight variation ratio (dry weight variation divided by dry weight at day 1) was a continuous non normally distributed variable for which we performed Wilcoxon rank sum tests and Student's t-tests. Dry weight variations were bigger in patients infected with SARSCov-2 compared to non-infected patients: the mean dry weight variation ratio was - 2,4 +/- 2,2% (SD) in the infected dialysis patients and - 0,6 +/- 2,0% in the uninfected patients (p < 0.001). A very strong association was found between SARSCov-2 infection and loss of dry weight (0,5 kg and more) with odds ratio = 21,89;95% CI [7,17-66,85]. No difference was found whether infected patients were symptomatic or not (-2,6 +/- 2,2% vs - 2,3 +/- 2,3%;p = 0,662). Infected patients and non-infected patients significantly differ by the sex distribution (76% vs 52% males;p = 0,008). We performed a Cochran-Mantel-Haenszel stratified analysis and confirmed the association between loss of dry weight and SARSCov-2 infection after controlling for effect modification or confounding by sex. Furthermore, dry weight often varies during early haemodialysis sessions and a bias such as a short dialysis duration was also ruled out. Indeed, no correlation was found between the shortest dialysis durations (less than 2 months) and the dry weight variations observed in our population. Discussion(s): SARSCov-2 infection is associated with decreases of dry weight
背景干重被定义为透析后最低耐受重量,在该重量下,低血容量或高血容量的体征或症状最小。达到干重是每个透析疗程的目标。这可以改善透析患者的血压控制,降低心血管风险。当分解代谢反应和炎症发生时,血液透析患者可能会经历可能与干物质减少有关的体重减轻。我们的目的是评估SARSCov-2感染对血液透析患者的影响,并分析与新冠肺炎大流行期间观察到的干重变化相关的因素。方法:在这项回顾性观察性单中心研究中,我们分析了2020年3月1日至2022年2月28日新冠肺炎大流行期间在Pole Hospitalier Jolimont接受血液透析的所有患者的临床特征。我们在诊断为严重急性呼吸系统综合征冠状病毒2型感染后第1天或随机分配的28天观察期的第1天以及2、3和4周后测定干重。我们比较了感染和未感染的患者,并检查了与严重急性呼吸系统综合征冠状病毒2型感染相关的临床特征以及与干重变化相关的临床特点。结果:在观察期内,162名血液透析患者中,47名患者感染了严重急性呼吸系统综合征冠状病毒2型。三名患者因在第一次透析前感染而被排除在外,另有十七名患者因数据缺失而被排除。两名患者被感染了两次,但我们认为第二次发作是相关的,因此进行了144次观察。干重变异比(干重变异除以第1天的干重)是一个连续的非正态分布变量,我们对此进行了Wilcoxon秩和检验和Student t检验。与未感染的患者相比,感染严重急性呼吸系统综合征冠状病毒2型的患者的干重变化更大:感染透析患者的平均干重变化率为-2,4+/-2,2%(SD),未感染患者为-0.6+/-2,0%(p<0.001);95%置信区间[7,17-66,85]。感染患者是否有症状没有发现差异(-2,6+/-2,2%与-2,3+/-2,3%;p=0.062)。感染患者和未感染患者的性别分布有显著差异(76%对52%的男性;p=0.008)。我们进行了Cochran-Mantel-Haenszel分层分析,并在控制了性别影响或混淆后,证实了干重损失与严重急性呼吸系统综合征冠状病毒2型感染之间的相关性。此外,干重在早期血液透析期间经常变化,也排除了透析时间短等偏差。事实上,在我们的人群中观察到的最短透析持续时间(不到2个月)和干重变化之间没有发现相关性。讨论:严重急性呼吸系统综合征冠状病毒2型感染与血液透析患者干重下降有关。怀疑严重急性呼吸系统综合征冠状病毒2型感染的系统影响,因为有症状和无症状感染的透析患者的干重变化非常相似。在我们的人群中,只有2名患者死于与严重急性呼吸系统综合征冠状病毒2型感染相关的并发症。适应干重可能是降低感染透析患者死亡率的主要因素。
{"title":"Abstracts presented at the 26th Annual Congress of the Belgian Society of Internal Medicine, 9-10 December 2022, Dolce La Hulpe, La Hulpe, Belgium","authors":"Liselot Vandenbergen, Charline Leclercq, J. D. Greef, J. Yombi, H. Yildiz, Veerle Beckers, Shula Staessens, Sabine Allard, Rik Schots, L. Pothen, Ana Strezova, Javier Diez-Domingo, Kamal Al Shawafi, Juan Carlos Tinoco, Meng Shi, Paola Pirrotta, Angnes Mwakingwe-Omari, Florence Strubbe, Hernan Valdes-Socin, O. Calvete, Javier Benitez, Edouard Louis, P. Petrossians, S. Henrard, Nicola Trotta, Tim Coolen, Delphine Puttaert, J. Goffard, J. Vooren","doi":"10.1080/17843286.2022.2149807","DOIUrl":"https://doi.org/10.1080/17843286.2022.2149807","url":null,"abstract":"Background Dry weight is defined as the lowest tolerated post-dialysis weight at which there are minimal signs or symptoms of hypovolemia or hypervolemia. Achieving dry weight is a goal for each dialysis session. That improves blood pressure control and reduces cardiovascular risk in dialysis patients. Haemodialysis patients may experience weight loss likely related to a reduction of dry mass when catabolic reactions and inflammation occur. Our aim was to assess the impact of SARSCov-2 infection on haemodialysis patients and analyse factors associated with dry weight variations observed during the COVID-19 pandemic. Method(s): In this retrospective observational single-centre study, we analysed the clinical characteristics of all patients undergoing haemodialysis at the Pole Hospitalier Jolimont during COVID-19 pandemic from 1 March 2020 to 28 February 2022. We determined dry weight at day 1 after diagnosis of SARSCov-2 infection or at day 1 of a randomly assigned 28-days observation period and at 2, 3 and 4 weeks later. We compared infected and uninfected patients and examined the clinical features associated with SARSCov-2 infection and those associated with changes in dry weight. Result(s): Within the observation period, among the 162 haemodialysis patients, 47 patients were infected with SARSCov-2. Three patients were excluded because they have been infected before the first dialysis session and seventeen others due to missing data. Two patients were infected twice but we considered the second episodes as relevant and had therefore 144 observations. Dry weight variation ratio (dry weight variation divided by dry weight at day 1) was a continuous non normally distributed variable for which we performed Wilcoxon rank sum tests and Student's t-tests. Dry weight variations were bigger in patients infected with SARSCov-2 compared to non-infected patients: the mean dry weight variation ratio was - 2,4 +/- 2,2% (SD) in the infected dialysis patients and - 0,6 +/- 2,0% in the uninfected patients (p < 0.001). A very strong association was found between SARSCov-2 infection and loss of dry weight (0,5 kg and more) with odds ratio = 21,89;95% CI [7,17-66,85]. No difference was found whether infected patients were symptomatic or not (-2,6 +/- 2,2% vs - 2,3 +/- 2,3%;p = 0,662). Infected patients and non-infected patients significantly differ by the sex distribution (76% vs 52% males;p = 0,008). We performed a Cochran-Mantel-Haenszel stratified analysis and confirmed the association between loss of dry weight and SARSCov-2 infection after controlling for effect modification or confounding by sex. Furthermore, dry weight often varies during early haemodialysis sessions and a bias such as a short dialysis duration was also ruled out. Indeed, no correlation was found between the shortest dialysis durations (less than 2 months) and the dry weight variations observed in our population. Discussion(s): SARSCov-2 infection is associated with decreases of dry weight","PeriodicalId":7086,"journal":{"name":"Acta Clinica Belgica","volume":null,"pages":null},"PeriodicalIF":1.6,"publicationDate":"2022-12-05","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"42470410","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 1
A novel pathogenic variant in LCAT causing FLD. A case report. LCAT引起FLD的一种新的致病变异。一份病例报告。
IF 1.6 4区 医学 Q2 Medicine Pub Date : 2022-12-01 DOI: 10.1080/17843286.2021.2007598
Nuria Goñi Ros, Ricardo González-Tarancón, Paula Sienes Bailo, Elvira Salvador-Ruperez, Martín Puzo Bayod, José Puzo Foncillas

Background: Fish-eye disease (FED) is due to a partial deficiency in LCAT activity. Nevertheless, Familial lecithin-cholesterol acyltransferase deficiency (FLD), also called Norum disease, appears when the deficiency is complete. They are both rare genetic disorders inherited in an autosomal recessive manner. Clinical signs include decreased circulating HDL cholesterol and dense corneal opacity. Kidney injuries also affect patients suffering from FLD. The diagnosis of FLD is based on the presence of characteristic signs and symptoms and confirmed by genetic testing.

Case presentation: We present a case of a 63-year-old man showing an altered lipid profile with low HDL cholesterol, chronic kidney disease (CKD) and corneal disorders. He was referred to genetic counseling in order to discard genetic LCAT deficiency due to decreased visual acuity caused by corneal opacity. A massive DNA sequencing was conducted using a multigene panel associated with lipid metabolism disturbances.

Results and genetic findings: Two likely pathogenic variants in LCAT were identified and later confirmed by Sanger sequencing. Both (c.491 G > A and c.496 G > A) were missense variants that originated an amino acid substitution (164Arginine for Histidine and 166Alanine for Threonine, respectively) modifying the protein sequence and its 3D structure.

Conclusions: FLD and FED sharing common biochemical features, and the existence of other diseases with similar clinical profiles underline the need for a timely differential diagnosis aiming to address patients to preventive programs and future available therapies. This case, added to the reduced number of publications previously reported regarding FLD and FED, contributes to better understanding the genetic characteristics, clinical features, and diagnosis of these syndromes.

背景:鱼眼病(FED)是由于LCAT活性的部分缺乏。然而,家族性卵磷脂-胆固醇酰基转移酶缺乏症(FLD),也称为Norum病,在完全缺乏时出现。它们都是以常染色体隐性遗传方式遗传的罕见遗传病。临床症状包括循环高密度脂蛋白胆固醇降低和密集的角膜混浊。肾损伤也会影响FLD患者。FLD的诊断是基于特征体征和症状的存在,并通过基因检测证实。病例介绍:我们报告一例63岁的男性表现为低HDL胆固醇,慢性肾脏疾病(CKD)和角膜疾病的血脂改变。他被转介到遗传咨询,以消除由于角膜混浊导致的视力下降而导致的遗传性LCAT缺陷。使用与脂质代谢紊乱相关的多基因面板进行了大量DNA测序。结果和遗传发现:确定了LCAT的两种可能的致病变异,并随后通过Sanger测序证实。两个(c.491G > A, c.496G > A)是产生氨基酸取代的错义变异(164Arginine取代组氨酸,166Alanine取代苏氨酸),改变了蛋白质序列及其三维结构。结论:FLD和FED具有共同的生化特征,并且存在其他具有类似临床特征的疾病,这强调了及时鉴别诊断的必要性,旨在向患者提供预防方案和未来可用的治疗方法。这一病例,加上之前报道的关于FLD和FED的出版物数量减少,有助于更好地了解这些综合征的遗传特征、临床特征和诊断。
{"title":"A novel pathogenic variant in LCAT causing FLD. A case report.","authors":"Nuria Goñi Ros,&nbsp;Ricardo González-Tarancón,&nbsp;Paula Sienes Bailo,&nbsp;Elvira Salvador-Ruperez,&nbsp;Martín Puzo Bayod,&nbsp;José Puzo Foncillas","doi":"10.1080/17843286.2021.2007598","DOIUrl":"https://doi.org/10.1080/17843286.2021.2007598","url":null,"abstract":"<p><strong>Background: </strong>Fish-eye disease (FED) is due to a partial deficiency in LCAT activity. Nevertheless, Familial lecithin-cholesterol acyltransferase deficiency (FLD), also called Norum disease, appears when the deficiency is complete. They are both rare genetic disorders inherited in an autosomal recessive manner. Clinical signs include decreased circulating HDL cholesterol and dense corneal opacity. Kidney injuries also affect patients suffering from FLD. The diagnosis of FLD is based on the presence of characteristic signs and symptoms and confirmed by genetic testing.</p><p><strong>Case presentation: </strong>We present a case of a 63-year-old man showing an altered lipid profile with low HDL cholesterol, chronic kidney disease (CKD) and corneal disorders. He was referred to genetic counseling in order to discard genetic LCAT deficiency due to decreased visual acuity caused by corneal opacity. A massive DNA sequencing was conducted using a multigene panel associated with lipid metabolism disturbances.</p><p><strong>Results and genetic findings: </strong>Two likely pathogenic variants in <i>LCAT</i> were identified and later confirmed by Sanger sequencing. Both (c.491 G > A and c.496 G > A) were missense variants that originated an amino acid substitution (164Arginine for Histidine and 166Alanine for Threonine, respectively) modifying the protein sequence and its 3D structure.</p><p><strong>Conclusions: </strong>FLD and FED sharing common biochemical features, and the existence of other diseases with similar clinical profiles underline the need for a timely differential diagnosis aiming to address patients to preventive programs and future available therapies. This case, added to the reduced number of publications previously reported regarding FLD and FED, contributes to better understanding the genetic characteristics, clinical features, and diagnosis of these syndromes.</p>","PeriodicalId":7086,"journal":{"name":"Acta Clinica Belgica","volume":null,"pages":null},"PeriodicalIF":1.6,"publicationDate":"2022-12-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"9324982","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Analysis of ergonomic occupational accidents and near misses in a large Belgian university hospital. 比利时某大型大学医院人体工程学职业事故及未遂事故分析。
IF 1.6 4区 医学 Q2 Medicine Pub Date : 2022-12-01 Epub Date: 2021-12-14 DOI: 10.1080/17843286.2021.2015553
Norbert Fraeyman, Dirk de Bacquer, Els Clays, Tom Fiers, Lode Godderis, Rik Verhaeghe, Leen Viaene, Eric Mortier

Introduction: Health-care organizations are facing a high burden of ergonomic occupational accidents, and prevention is a continuous point of interest. In this manuscript, we describe the characteristics of ergonomic accidents in a large Belgian university hospital and discuss the value of near misses.

Methods: Combining databases, we identified the frequency [number of accidents × 106 hours worked per year], severity (number of days off work × 103 hours worked per year), and profile of the victims of occupational ergonomic accidents (with absence from work) or incidents or near-misses (without absence from work). Ergonomic accidents and incidents include slips, trips, falls, injurious body movements, overexertion, and handling heavy weights.

Results: In a period of 23 years, we noticed a significant decrease in the frequency of ergonomic accidents (from about 7 to about 4 standard units), without changes in the severity. The decrease in the frequency of accidents is mirrored by an increase in the frequency of incidents (from about 4 to about 6 standard units). Female and older employees are more vulnerable to accidents, and the frequency was between two and four times higher for employees mostly involved in manual tasks compared to employees mostly involved in managerial tasks. The profile of the victims and the causes of accidents and incidents were identical.

Conclusion: Although it is premature to assume a cause-consequence relationship between incidents and accidents, it is tempting to speculate that the increased ratio of the frequencies of incidents over accidents might be one of the variables reflecting the adequacy of preventive measures and the growth of safety behavior.

导读:卫生保健组织正面临着人体工程学职业事故的高负担,预防是一个持续的关注点。在这篇文章中,我们描述了在一个大型比利时大学医院的人体工程学事故的特点,并讨论了险些脱险的价值。方法:结合数据库,我们确定了频率[事故数量×每年工作106小时],严重程度(休假天数×每年工作103小时)以及职业人体工程学事故(缺勤)或事故或未遂事故(不缺勤)的受害者概况。人体工程学事故和事故包括滑倒、绊倒、跌倒、伤害身体的动作、过度劳累和搬运重物。结果:在23年的时间里,我们注意到人体工程学事故的频率明显下降(从大约7个标准单位下降到大约4个标准单位),但严重程度没有变化。事故发生频率的下降反映在事故发生频率的增加上(从大约4个标准单位增加到大约6个标准单位)。女性和年龄较大的员工更容易发生事故,主要从事体力劳动的员工发生事故的频率是主要从事管理工作的员工的2到4倍。受害者的轮廓和事故和事件的原因是相同的。结论:虽然假设事件和事故之间的因果关系还为时过早,但我们很容易推测,事件频率与事故频率之比的增加可能是反映预防措施是否充分和安全行为是否增长的变量之一。
{"title":"Analysis of ergonomic occupational accidents and near misses in a large Belgian university hospital.","authors":"Norbert Fraeyman,&nbsp;Dirk de Bacquer,&nbsp;Els Clays,&nbsp;Tom Fiers,&nbsp;Lode Godderis,&nbsp;Rik Verhaeghe,&nbsp;Leen Viaene,&nbsp;Eric Mortier","doi":"10.1080/17843286.2021.2015553","DOIUrl":"https://doi.org/10.1080/17843286.2021.2015553","url":null,"abstract":"<p><strong>Introduction: </strong>Health-care organizations are facing a high burden of ergonomic occupational accidents, and prevention is a continuous point of interest. In this manuscript, we describe the characteristics of ergonomic accidents in a large Belgian university hospital and discuss the value of near misses.</p><p><strong>Methods: </strong>Combining databases, we identified the frequency [number of accidents × 10<sup>6</sup> hours worked per year], severity (number of days off work × 10<sup>3</sup> hours worked per year), and profile of the victims of occupational ergonomic accidents (with absence from work) or incidents or near-misses (without absence from work). Ergonomic accidents and incidents include slips, trips, falls, injurious body movements, overexertion, and handling heavy weights.</p><p><strong>Results: </strong>In a period of 23 years, we noticed a significant decrease in the frequency of ergonomic accidents (from about 7 to about 4 standard units), without changes in the severity. The decrease in the frequency of accidents is mirrored by an increase in the frequency of incidents (from about 4 to about 6 standard units). Female and older employees are more vulnerable to accidents, and the frequency was between two and four times higher for employees mostly involved in manual tasks compared to employees mostly involved in managerial tasks. The profile of the victims and the causes of accidents and incidents were identical.</p><p><strong>Conclusion: </strong>Although it is premature to assume a cause-consequence relationship between incidents and accidents, it is tempting to speculate that the increased ratio of the frequencies of incidents over accidents might be one of the variables reflecting the adequacy of preventive measures and the growth of safety behavior.</p>","PeriodicalId":7086,"journal":{"name":"Acta Clinica Belgica","volume":null,"pages":null},"PeriodicalIF":1.6,"publicationDate":"2022-12-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"39586257","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 2
Not a wild goose chase: long-lasting MRSA negative status following eradication therapy for chronic MRSA infection in patients with cystic fibrosis. 不是徒劳的追逐:囊性纤维化患者慢性MRSA感染根除治疗后长期MRSA阴性。
IF 1.6 4区 医学 Q2 Medicine Pub Date : 2022-12-01 Epub Date: 2021-12-07 DOI: 10.1080/17843286.2021.2012948
Stefanie Vincken, Sylvia Verbanck, Shane Hanon, Eef Vanderhelst

Objectives: Prevalence of MRSA in patients with CF has risen over the past decades, and chronic infection with MRSA is associated with worse outcome in this patient group.

Methods: This retrospective observational study investigated long-term eradication rate in pediatric and adult CF patients with chronic MRSA infection, using a 6-month eradication regimen containing 2 oral antibiotics, combined with topical decolonisation measures. Respiratory tract cultures were performed at least every three months, from the first MRSA-positive culture onwards.

Results: A total of 24 patients with chronic MRSA infection were identified from our CF patient registry, of which 13 patients underwent an eradication attempt. The regimen consisted of 2 oral antibiotics: a combination of rifampicin, fusidic acid, clindamycin and co-trimoxazol, based on the sensitivity pattern of the MRSA strain. At the end of the study period (median 8.2 years), 12 out of 13 patients (92%) were MRSA negative. None of the patients interrupted treatment due to side-effects.

Conclusions: Eradication of chronic MRSA infection is feasible, well-tolerated and highly successful, and can offer a long-lasting MRSA-negative status, obviating the need for patient segregation.

目的:在过去的几十年里,CF患者中MRSA的患病率有所上升,在这一患者组中,MRSA的慢性感染与较差的预后相关。方法:这项回顾性观察性研究调查了慢性MRSA感染的儿童和成人CF患者的长期根除率,采用6个月的根除方案,包括2种口服抗生素,结合局部去殖措施。从第一次mrsa阳性培养开始,至少每三个月进行一次呼吸道培养。结果:共有24例慢性MRSA感染患者从我们的CF患者登记册中确定,其中13例患者进行了根除尝试。该方案包括2种口服抗生素:利福平、夫西地酸、克林霉素和复方新恶唑的组合,基于MRSA菌株的敏感性模式。在研究期结束时(中位8.2年),13名患者中有12名(92%)为MRSA阴性。没有患者因副作用而中断治疗。结论:根除慢性MRSA感染是可行的,耐受性良好且非常成功,并且可以提供长期的MRSA阴性状态,避免了患者隔离的需要。
{"title":"Not a wild goose chase: long-lasting MRSA negative status following eradication therapy for chronic MRSA infection in patients with cystic fibrosis.","authors":"Stefanie Vincken,&nbsp;Sylvia Verbanck,&nbsp;Shane Hanon,&nbsp;Eef Vanderhelst","doi":"10.1080/17843286.2021.2012948","DOIUrl":"https://doi.org/10.1080/17843286.2021.2012948","url":null,"abstract":"<p><strong>Objectives: </strong>Prevalence of MRSA in patients with CF has risen over the past decades, and chronic infection with MRSA is associated with worse outcome in this patient group.</p><p><strong>Methods: </strong>This retrospective observational study investigated long-term eradication rate in pediatric and adult CF patients with chronic MRSA infection, using a 6-month eradication regimen containing 2 oral antibiotics, combined with topical decolonisation measures. Respiratory tract cultures were performed at least every three months, from the first MRSA-positive culture onwards.</p><p><strong>Results: </strong>A total of 24 patients with chronic MRSA infection were identified from our CF patient registry, of which 13 patients underwent an eradication attempt. The regimen consisted of 2 oral antibiotics: a combination of rifampicin, fusidic acid, clindamycin and co-trimoxazol, based on the sensitivity pattern of the MRSA strain. At the end of the study period (median 8.2 years), 12 out of 13 patients (92%) were MRSA negative. None of the patients interrupted treatment due to side-effects.</p><p><strong>Conclusions: </strong>Eradication of chronic MRSA infection is feasible, well-tolerated and highly successful, and can offer a long-lasting MRSA-negative status, obviating the need for patient segregation.</p>","PeriodicalId":7086,"journal":{"name":"Acta Clinica Belgica","volume":null,"pages":null},"PeriodicalIF":1.6,"publicationDate":"2022-12-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"39699363","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Treatment of patients with newly diagnosed metastatic hormone sensitive prostate cancer (mHSPC) in Belgium: a real world data analysis. 比利时新诊断的转移性激素敏感前列腺癌(mHSPC)患者的治疗:真实世界的数据分析。
IF 1.6 4区 医学 Q2 Medicine Pub Date : 2022-12-01 Epub Date: 2021-11-18 DOI: 10.1080/17843286.2021.2001999
E Lambert, S Hollebosch, C van Praet, S Van Bruwaene, L Duck, W De Roock, S van Wambeke, C Ghysel, F Ameye, P Schatteman, F Vandenbroucke, B Sautois, F Baekelandt, D Ost, K Fransis, B Filleul, C Remondo, W Wynendaele, B Bamelis, P Logghe, E Vergauwe, E Denies, S Joniau, N Lumen

Introduction: Abiraterone acetate + prednisone (AAP) and docetaxel have proven their efficacy in the treatment of patients with newly diagnosed metastatic hormone-sensitive prostate cancer (mHSPC) in clinical trials. However, real-world data are scarce. The goal of this study is to evaluate real-world data on the efficacy and safety of these therapies in mHSPC patients.

Patients and methods: Records of 93 patients from 21 different centres were retrospectively reviewed. Primary and secondary endpoints were radiographic and PSA progression-free survival (RPFS - PSA-PFS) and cancer specific and overall survival (CSS - OS), respectively. Adverse events (AEs) were evaluated according to the Common Terminology Criteria for Adverse Events version 5.0. Differences in oncological outcome and AEs were evaluated between three treatment groups: ADT only (N=26) - ADT + AAP (N=48) - ADT + docetaxel (N=19). Survival analysis was performed using Kaplan-Meier statistics.

Results: Median RPFS was 13 months (95% confidence interval [CI]: 9-17) for ADT only, 21 months (95% CI: 19-23) for ADT + AAP and 12 months (95% CI: 11-14) for ADT + docetaxel (p = 0.004). The 1-year PSA-PFS, CSS and OS were 73.5%, 90.7% and 88.7%, respectively, with no significant differences between the three groups. Adverse events of grade 3 or higher were not observed more frequently.

Conclusion: Retrospective real-world data show a significantly longer RPFS for mHSPC patients treated with ADT + AAP compared to ADT only or ADT + docetaxel at short-term follow-up. This can aid in counselling of mHSPC patients in daily clinical practice.

简介:在临床试验中,醋酸阿比龙+强的松(AAP)和多西他赛治疗新诊断的转移性激素敏感性前列腺癌(mHSPC)患者的疗效得到了证实。然而,真实世界的数据很少。本研究的目的是评估这些疗法在mHSPC患者中的有效性和安全性的真实数据。患者和方法:回顾性分析来自21个不同中心的93例患者的记录。主要终点和次要终点分别是放射学和PSA无进展生存期(RPFS - PSA- pfs)和癌症特异性和总生存期(CSS - OS)。不良事件(ae)根据不良事件通用术语标准5.0版进行评估。评估三个治疗组之间肿瘤预后和ae的差异:仅ADT (N=26) - ADT + AAP (N=48) - ADT +多西紫杉醇(N=19)。生存分析采用Kaplan-Meier统计。结果:仅ADT的中位RPFS为13个月(95%可信区间[CI]: 9-17), ADT + AAP的中位RPFS为21个月(95% CI: 19-23), ADT +多西他赛的中位RPFS为12个月(95% CI: 11-14) (p = 0.004)。1年PSA-PFS、CSS和OS分别为73.5%、90.7%和88.7%,三组间差异无统计学意义。3级及以上不良事件的发生率不高。结论:现实世界的回顾性数据显示,在短期随访中,ADT + AAP治疗的mHSPC患者的RPFS明显长于单纯ADT或ADT +多西他赛。这可以帮助咨询mHSPC患者在日常临床实践。
{"title":"Treatment of patients with newly diagnosed metastatic hormone sensitive prostate cancer (mHSPC) in Belgium: a real world data analysis.","authors":"E Lambert,&nbsp;S Hollebosch,&nbsp;C van Praet,&nbsp;S Van Bruwaene,&nbsp;L Duck,&nbsp;W De Roock,&nbsp;S van Wambeke,&nbsp;C Ghysel,&nbsp;F Ameye,&nbsp;P Schatteman,&nbsp;F Vandenbroucke,&nbsp;B Sautois,&nbsp;F Baekelandt,&nbsp;D Ost,&nbsp;K Fransis,&nbsp;B Filleul,&nbsp;C Remondo,&nbsp;W Wynendaele,&nbsp;B Bamelis,&nbsp;P Logghe,&nbsp;E Vergauwe,&nbsp;E Denies,&nbsp;S Joniau,&nbsp;N Lumen","doi":"10.1080/17843286.2021.2001999","DOIUrl":"https://doi.org/10.1080/17843286.2021.2001999","url":null,"abstract":"<p><strong>Introduction: </strong>Abiraterone acetate + prednisone (AAP) and docetaxel have proven their efficacy in the treatment of patients with newly diagnosed metastatic hormone-sensitive prostate cancer (mHSPC) in clinical trials. However, real-world data are scarce. The goal of this study is to evaluate real-world data on the efficacy and safety of these therapies in mHSPC patients.</p><p><strong>Patients and methods: </strong>Records of 93 patients from 21 different centres were retrospectively reviewed. Primary and secondary endpoints were radiographic and PSA progression-free survival (RPFS - PSA-PFS) and cancer specific and overall survival (CSS - OS), respectively. Adverse events (AEs) were evaluated according to the Common Terminology Criteria for Adverse Events version 5.0. Differences in oncological outcome and AEs were evaluated between three treatment groups: ADT only (N=26) - ADT + AAP (N=48) - ADT + docetaxel (N=19). Survival analysis was performed using Kaplan-Meier statistics.</p><p><strong>Results: </strong>Median RPFS was 13 months (95% confidence interval [CI]: 9-17) for ADT only, 21 months (95% CI: 19-23) for ADT + AAP and 12 months (95% CI: 11-14) for ADT + docetaxel (p = 0.004). The 1-year PSA-PFS, CSS and OS were 73.5%, 90.7% and 88.7%, respectively, with no significant differences between the three groups. Adverse events of grade 3 or higher were not observed more frequently.</p><p><strong>Conclusion: </strong>Retrospective real-world data show a significantly longer RPFS for mHSPC patients treated with ADT + AAP compared to ADT only or ADT + docetaxel at short-term follow-up. This can aid in counselling of mHSPC patients in daily clinical practice.</p>","PeriodicalId":7086,"journal":{"name":"Acta Clinica Belgica","volume":null,"pages":null},"PeriodicalIF":1.6,"publicationDate":"2022-12-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"39899390","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 1
Vitamin B12 deficiency in the setting of nitrous oxide abuse: diagnostic challenges and treatment options in patients presenting with subacute neurological complications. 一氧化氮滥用背景下的维生素B12缺乏:亚急性神经系统并发症患者的诊断挑战和治疗选择
IF 1.6 4区 医学 Q2 Medicine Pub Date : 2022-12-01 Epub Date: 2021-12-09 DOI: 10.1080/17843286.2021.2015555
Yasmine Sluyts, Pieternel Vanherpe, Rizvana Amir, Filip Vanhoenacker, Pieter Vermeersch

Objective: It is well recognized that nitrous oxide abuse can lead to vitamin B12 deficiency presenting with neurological complications. Nevertheless, establishing this diagnosis can be challenging, and treatment guidelines are lacking.

Methods: In this paper, we present a case series of eight patients and discuss the diagnostic challenges and treatment options for vitamin B12 deficiency due to nitrous oxide abuse presenting with neurologic complications.

Results: Biochemical findings are not always straightforward and complementary testing is often necessary. Magnetic Resonance Imaging (MRI) revealed a longitudinally myelopathy extending over a long segment typically involving the dorsal columns of the cervical cord. To increase the lesion conspicuity, dedicated MRI sequences are needed. In our practice, we recommend the use of T2-weighted images (WI) with fat suppression (FS). Treatment consists of cessation of nitrous oxide abuse and supplementation with intramuscular injections of cobalamin. Due to a lack of treatment guidelines, we also describe the treatment schedule used in our neurology clinic and give a brief overview of treatment options suggested in the literature.

Conclusion: We described diagnostic steps en treatment plans in patients presenting with subacute neurological complications due to nitrous oxide abuse.

Abbreviations: crea: creatinine; HCy: homocysteine; MCA: 2-methylcitric acid; MMA: methylmalonic acid; MRI: magnetic resonance imaging; SEP: somatosensory evoked potentials.

目的:众所周知,滥用一氧化二氮可导致维生素B12缺乏症,并伴有神经系统并发症。然而,建立这种诊断可能具有挑战性,并且缺乏治疗指南。方法:在本文中,我们报告了8例患者的病例系列,并讨论了因滥用一氧化二氮导致的维生素B12缺乏症的诊断挑战和治疗方案,并伴有神经系统并发症。结果:生化结果并不总是直截了当的,经常需要补充检测。磁共振成像(MRI)显示纵向脊髓病延伸到一长段,典型地累及颈髓背柱。为了增加病变的显著性,需要专门的MRI序列。在我们的实践中,我们建议使用脂肪抑制(FS)的t2加权图像(WI)。治疗包括停止滥用一氧化二氮和补充肌肉注射钴胺素。由于缺乏治疗指南,我们也描述了我们神经病学诊所使用的治疗方案,并简要概述了文献中建议的治疗方案。结论:我们描述了因滥用一氧化二氮而出现亚急性神经系统并发症的患者的诊断步骤和治疗方案。缩写:crea:肌酐;HCy:同型半胱氨酸;MCA: 2-甲基柠檬酸;MMA:甲基丙二酸;MRI:磁共振成像;SEP:躯体感觉诱发电位。
{"title":"Vitamin B<sub>12</sub> deficiency in the setting of nitrous oxide abuse: diagnostic challenges and treatment options in patients presenting with subacute neurological complications.","authors":"Yasmine Sluyts,&nbsp;Pieternel Vanherpe,&nbsp;Rizvana Amir,&nbsp;Filip Vanhoenacker,&nbsp;Pieter Vermeersch","doi":"10.1080/17843286.2021.2015555","DOIUrl":"https://doi.org/10.1080/17843286.2021.2015555","url":null,"abstract":"<p><strong>Objective: </strong>It is well recognized that nitrous oxide abuse can lead to vitamin B<sub>12</sub> deficiency presenting with neurological complications. Nevertheless, establishing this diagnosis can be challenging, and treatment guidelines are lacking.</p><p><strong>Methods: </strong>In this paper, we present a case series of eight patients and discuss the diagnostic challenges and treatment options for vitamin B<sub>12</sub> deficiency due to nitrous oxide abuse presenting with neurologic complications.</p><p><strong>Results: </strong>Biochemical findings are not always straightforward and complementary testing is often necessary. Magnetic Resonance Imaging (MRI) revealed a longitudinally myelopathy extending over a long segment typically involving the dorsal columns of the cervical cord. To increase the lesion conspicuity, dedicated MRI sequences are needed. In our practice, we recommend the use of T2-weighted images (WI) with fat suppression (FS). Treatment consists of cessation of nitrous oxide abuse and supplementation with intramuscular injections of cobalamin. Due to a lack of treatment guidelines, we also describe the treatment schedule used in our neurology clinic and give a brief overview of treatment options suggested in the literature.</p><p><strong>Conclusion: </strong>We described diagnostic steps en treatment plans in patients presenting with subacute neurological complications due to nitrous oxide abuse.</p><p><strong>Abbreviations: </strong>crea: creatinine; HCy: homocysteine; MCA: 2-methylcitric acid; MMA: methylmalonic acid; MRI: magnetic resonance imaging; SEP: somatosensory evoked potentials.</p>","PeriodicalId":7086,"journal":{"name":"Acta Clinica Belgica","volume":null,"pages":null},"PeriodicalIF":1.6,"publicationDate":"2022-12-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"39586210","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 8
SARS-CoV-2 seroprevalence in high-risk health care workers in a Belgian general hospital: evolution from the first wave to the second. 比利时某综合医院高危医护人员SARS-CoV-2血清阳性率:从第一波到第二波的演变
IF 1.6 4区 医学 Q2 Medicine Pub Date : 2022-12-01 Epub Date: 2021-11-18 DOI: 10.1080/17843286.2021.2004349
Loris Wauthier, Quentin Delefortrie, Nicolas Eppe, Patrick Vankerkhoven, Eva Wolff, Mélanie Dekeyser, Jean-Michel Cirriez, Alexandre Grimmelprez

Health care workers (HCWs) are at the frontline for combatting the ongoing severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) pandemic. To describe recent or past infections, the novel development of serological assays enabled the assessment of the immune response developed in coronavirus disease (COVID-19). Here, we investigate SARS-CoV-2 seroprevalence in high-risk HCWs in a Belgian general hospital after both the first and the second waves. Three different immunoassays were used to determine immune response to SARS-CoV-2 in volunteer HCWs who worked in at least one COVID-19-dedicated ward [emergency department, intensive care unit (ICU) and internal medicine department] in our institution from 8 May 2020 to 19 May 2020 (n = 267) and from 18 January 2021 to 8 February 2021 (n = 189). Risk factors for seropositivity were also assessed using a questionnaire filled out by all participants. We report a steep increase in seroprevalence after the second wave and report a higher seropositivity in HCWs than in the general population. Furthermore, we show that ICU personnel and especially nurses exhibit a proportionally lower SARS-CoV-2 seroprevalence. This study documents the rapid increase in SARS-CoV-2 seroprevalence in highly exposed HCWs in a context of high viral circulation prior to vaccination campaigns. Most importantly, it suggests a lower occupational risk in ICU and illustrates the role of diagnostic labeling and use of personal protective equipment during the COVID-19 pandemic.

卫生保健工作者(HCWs)处于抗击持续的严重急性呼吸综合征冠状病毒2 (SARS-CoV-2)大流行的第一线。为了描述最近或过去的感染,血清学检测的新发展使评估冠状病毒病(COVID-19)中产生的免疫反应成为可能。在这里,我们调查了比利时一家综合医院的高危医护人员在第一波和第二波后的SARS-CoV-2血清阳性率。2020年5月8日至2020年5月19日(n = 267)和2021年1月18日至2021年2月8日(n = 189)在我院至少一个covid -19专用病房(急诊科、重症监护病房(ICU)和内科)工作的志愿医护人员,采用三种不同的免疫测定法测定其对SARS-CoV-2的免疫反应。所有参与者还填写了一份调查问卷,对血清阳性的危险因素进行了评估。我们报告了第二波之后血清阳性率的急剧上升,并且报告了HCWs的血清阳性高于一般人群。此外,我们发现ICU人员,特别是护士的SARS-CoV-2血清阳性率比例较低。本研究记录了在疫苗接种运动之前高病毒传播背景下,高度暴露的卫生保健工作者的SARS-CoV-2血清阳性率迅速上升。最重要的是,这表明ICU的职业风险较低,并说明了在COVID-19大流行期间诊断标签和个人防护装备使用的作用。
{"title":"SARS-CoV-2 seroprevalence in high-risk health care workers in a Belgian general hospital: evolution from the first wave to the second.","authors":"Loris Wauthier,&nbsp;Quentin Delefortrie,&nbsp;Nicolas Eppe,&nbsp;Patrick Vankerkhoven,&nbsp;Eva Wolff,&nbsp;Mélanie Dekeyser,&nbsp;Jean-Michel Cirriez,&nbsp;Alexandre Grimmelprez","doi":"10.1080/17843286.2021.2004349","DOIUrl":"https://doi.org/10.1080/17843286.2021.2004349","url":null,"abstract":"<p><p>Health care workers (HCWs) are at the frontline for combatting the ongoing severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) pandemic. To describe recent or past infections, the novel development of serological assays enabled the assessment of the immune response developed in coronavirus disease (COVID-19). Here, we investigate SARS-CoV-2 seroprevalence in high-risk HCWs in a Belgian general hospital after both the first and the second waves. Three different immunoassays were used to determine immune response to SARS-CoV-2 in volunteer HCWs who worked in at least one COVID-19-dedicated ward [emergency department, intensive care unit (ICU) and internal medicine department] in our institution from 8 May 2020 to 19 May 2020 (<i>n</i> = 267) and from 18 January 2021 to 8 February 2021 (<i>n</i> = 189). Risk factors for seropositivity were also assessed using a questionnaire filled out by all participants. We report a steep increase in seroprevalence after the second wave and report a higher seropositivity in HCWs than in the general population. Furthermore, we show that ICU personnel and especially nurses exhibit a proportionally lower SARS-CoV-2 seroprevalence. This study documents the rapid increase in SARS-CoV-2 seroprevalence in highly exposed HCWs in a context of high viral circulation prior to vaccination campaigns. Most importantly, it suggests a lower occupational risk in ICU and illustrates the role of diagnostic labeling and use of personal protective equipment during the COVID-19 pandemic.</p>","PeriodicalId":7086,"journal":{"name":"Acta Clinica Belgica","volume":null,"pages":null},"PeriodicalIF":1.6,"publicationDate":"2022-12-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"39741820","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 5
Laboratory analysis of two Delta SARS-CoV-2 variant outbreaks in the Port of Antwerp. 安特卫普港两起三角洲SARS-CoV-2变体暴发的实验室分析
IF 1.6 4区 医学 Q2 Medicine Pub Date : 2022-12-01 Epub Date: 2021-12-01 DOI: 10.1080/17843286.2021.2010966
Hélène L F Boogaerts, Patrick Smits, Guy Hans, Liza Bouly, Eline Coeck, Sarah Vandamme, Hilde Jansens, Herman Goossens, Veerle Matheeussen

Introduction: The B.1.617.2 SARS-CoV-2 or Delta variant, first detected in India, has shown a rapid global spread due to its high transmissibility and now represents more than 99% of the currently circulating variants in Europe.

Methods and result: In May 2021, two ships that had recently arrived in the Port of Antwerp reported crew members with COVID-like symptoms. SARS-CoV-2 RNA was detected in nasopharyngeal swabs in 30 out of 45 skippers and the B.1.617.2 variant was identified via whole genome sequencing. Crew members were isolated or quarantined and repeatedly tested to assess the evolution of their SARS-CoV-2 viral load based on the cycle threshold (CT) values of the PCR reaction. Viral cultures were also taken at day 7 to detect viable virus and were compared with the subjects CT value at that moment. The shipper's clinical condition was closely observed using a digital home monitoring tool. Eleven crew members (37%) required hospitalization, with CT values of SARS-CoV-2 RNA being a good predictive factor for the hospitalization need. Furthermore, a clear correlation between CT values and positive viral culture was observed, hinting infectiousness even longer than 10 days after the intitial positive PCR test.

Conclusion: Our study of 2 Delta variant clusters shows that the initial CT value is a good predictor for hospitalization need and suggests that patients infected with this variant may remain infectious for a longer time period.

在印度首次发现的B.1.617.2 SARS-CoV-2或Delta变体,由于其高传播性,已显示出快速的全球传播,目前占欧洲当前流行变体的99%以上。方法和结果:2021年5月,最近抵达安特卫普港的两艘船舶报告了船员出现类似covid - 19症状的情况。在45名船长中有30人的鼻咽拭子中检测到SARS-CoV-2 RNA,并通过全基因组测序鉴定出B.1.617.2变体。对机组人员进行隔离或隔离,并根据PCR反应的周期阈值(CT)反复检测,评估其SARS-CoV-2病毒载量的演变。在第7天进行病毒培养,检测活病毒,并与受试者当时的CT值进行比较。使用数字家庭监测工具密切观察托运人的临床状况。11名机组人员(37%)需要住院治疗,SARS-CoV-2 RNA的CT值是预测住院需求的良好因素。此外,观察到CT值与病毒培养阳性之间存在明显的相关性,提示在首次PCR检测阳性后10天以上仍具有传染性。结论:我们对2个Delta变异簇的研究表明,初始CT值是住院需求的良好预测指标,并提示感染该变异的患者可能在较长时间内保持传染性。
{"title":"Laboratory analysis of two Delta SARS-CoV-2 variant outbreaks in the Port of Antwerp.","authors":"Hélène L F Boogaerts,&nbsp;Patrick Smits,&nbsp;Guy Hans,&nbsp;Liza Bouly,&nbsp;Eline Coeck,&nbsp;Sarah Vandamme,&nbsp;Hilde Jansens,&nbsp;Herman Goossens,&nbsp;Veerle Matheeussen","doi":"10.1080/17843286.2021.2010966","DOIUrl":"https://doi.org/10.1080/17843286.2021.2010966","url":null,"abstract":"<p><strong>Introduction: </strong>The B.1.617.2 SARS-CoV-2 or Delta variant, first detected in India, has shown a rapid global spread due to its high transmissibility and now represents more than 99% of the currently circulating variants in Europe.</p><p><strong>Methods and result: </strong>In May 2021, two ships that had recently arrived in the Port of Antwerp reported crew members with COVID-like symptoms. SARS-CoV-2 RNA was detected in nasopharyngeal swabs in 30 out of 45 skippers and the B.1.617.2 variant was identified via whole genome sequencing. Crew members were isolated or quarantined and repeatedly tested to assess the evolution of their SARS-CoV-2 viral load based on the cycle threshold (CT) values of the PCR reaction. Viral cultures were also taken at day 7 to detect viable virus and were compared with the subjects CT value at that moment. The shipper's clinical condition was closely observed using a digital home monitoring tool. Eleven crew members (37%) required hospitalization, with CT values of SARS-CoV-2 RNA being a good predictive factor for the hospitalization need. Furthermore, a clear correlation between CT values and positive viral culture was observed, hinting infectiousness even longer than 10 days after the intitial positive PCR test.</p><p><strong>Conclusion: </strong>Our study of 2 Delta variant clusters shows that the initial CT value is a good predictor for hospitalization need and suggests that patients infected with this variant may remain infectious for a longer time period.</p>","PeriodicalId":7086,"journal":{"name":"Acta Clinica Belgica","volume":null,"pages":null},"PeriodicalIF":1.6,"publicationDate":"2022-12-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"39949419","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
期刊
Acta Clinica Belgica
全部 Acc. Chem. Res. ACS Applied Bio Materials ACS Appl. Electron. Mater. ACS Appl. Energy Mater. ACS Appl. Mater. Interfaces ACS Appl. Nano Mater. ACS Appl. Polym. Mater. ACS BIOMATER-SCI ENG ACS Catal. ACS Cent. Sci. ACS Chem. Biol. ACS Chemical Health & Safety ACS Chem. Neurosci. ACS Comb. Sci. ACS Earth Space Chem. ACS Energy Lett. ACS Infect. Dis. ACS Macro Lett. ACS Mater. Lett. ACS Med. Chem. Lett. ACS Nano ACS Omega ACS Photonics ACS Sens. ACS Sustainable Chem. Eng. ACS Synth. Biol. Anal. Chem. BIOCHEMISTRY-US Bioconjugate Chem. BIOMACROMOLECULES Chem. Res. Toxicol. Chem. Rev. Chem. Mater. CRYST GROWTH DES ENERG FUEL Environ. Sci. Technol. Environ. Sci. Technol. Lett. Eur. J. Inorg. Chem. IND ENG CHEM RES Inorg. Chem. J. Agric. Food. Chem. J. Chem. Eng. Data J. Chem. Educ. J. Chem. Inf. Model. J. Chem. Theory Comput. J. Med. Chem. J. Nat. Prod. J PROTEOME RES J. Am. Chem. Soc. LANGMUIR MACROMOLECULES Mol. Pharmaceutics Nano Lett. Org. Lett. ORG PROCESS RES DEV ORGANOMETALLICS J. Org. Chem. J. Phys. Chem. J. Phys. Chem. A J. Phys. Chem. B J. Phys. Chem. C J. Phys. Chem. Lett. Analyst Anal. Methods Biomater. Sci. Catal. Sci. Technol. Chem. Commun. Chem. Soc. Rev. CHEM EDUC RES PRACT CRYSTENGCOMM Dalton Trans. Energy Environ. Sci. ENVIRON SCI-NANO ENVIRON SCI-PROC IMP ENVIRON SCI-WAT RES Faraday Discuss. Food Funct. Green Chem. Inorg. Chem. Front. Integr. Biol. J. Anal. At. Spectrom. J. Mater. Chem. A J. Mater. Chem. B J. Mater. Chem. C Lab Chip Mater. Chem. Front. Mater. Horiz. MEDCHEMCOMM Metallomics Mol. Biosyst. Mol. Syst. Des. Eng. Nanoscale Nanoscale Horiz. Nat. Prod. Rep. New J. Chem. Org. Biomol. Chem. Org. Chem. Front. PHOTOCH PHOTOBIO SCI PCCP Polym. Chem.
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
0
微信
客服QQ
Book学术公众号 扫码关注我们
反馈
×
意见反馈
请填写您的意见或建议
请填写您的手机或邮箱
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
现在去查看 取消
×
提示
确定
Book学术官方微信
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术
文献互助 智能选刊 最新文献 互助须知 联系我们:info@booksci.cn
Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。
Copyright © 2023 Book学术 All rights reserved.
ghs 京公网安备 11010802042870号 京ICP备2023020795号-1